The Pharmacogenomics of Membrane Transporters Project: Research at the Interface of Genomics and Transporter Pharmacology
- 25 November 2009
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 87 (1) , 109-116
- https://doi.org/10.1038/clpt.2009.226
Abstract
Since the cloning of the first membrane transporter, our understanding of the role of transporters in clinical drug disposition and response has grown enormously. In parallel, large‐scale genome‐wide variation studies and the emerging field of pharmacogenomics have ushered in a new understanding of variations in drug response. At the crossroads of pharmacogenomics and transporter biology is the National Institutes of Health–funded Pharmacogenomics of Membrane Transporters (PMT) project, centered at the University of California, San Francisco. Clinical Pharmacology & Therapeutics (2010) 87 1, 109–116. doi:10.1038/clpt.2009.226Keywords
This publication has 34 references indexed in Scilit:
- Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1Pharmacogenetics and Genomics, 2009
- Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metforminPharmacogenetics and Genomics, 2009
- Functional Genetic Variation in the Basal Promoter of the Organic Cation/Carnitine Transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5)The Journal of Pharmacology and Experimental Therapeutics, 2009
- Identification and Characterization of Proximal Promoter Polymorphisms in the Human Concentrative Nucleoside Transporter 2 (SLC28A2)The Journal of Pharmacology and Experimental Therapeutics, 2009
- Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport functionThe Pharmacogenomics Journal, 2009
- Selecting Optimum Eukaryotic Integral Membrane Proteins for Structure Determination by Rapid Expression and Solubilization ScreeningJournal of Molecular Biology, 2009
- The Human Multidrug Resistance Protein 4 (MRP4, ABCC4): Functional Analysis of a Highly Polymorphic GeneThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Substrate-Dependent Effects of Human ABCB1 Coding PolymorphismsThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin PharmacokineticsClinical Pharmacology & Therapeutics, 2007
- Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin actionJournal of Clinical Investigation, 2007